Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass

International Journal of Obesity

Volumn 33, Issue 7, 2009, Pages 786-795

  Korner, J ^a   Inabnet, W ^a   Febres, G ^a   Conwell, I M ^a   McMahon, D J ^a   Salas, R ^a   Taveras, C ^a   Schrope, B ^a   Bessler, M ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Bariatric surgery; Ghrelin; GLP 1; Insulin secretion; Leptin; PYY

Indexed keywords

GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LEPTIN; PEPTIDE YY; THYROTROPIN; GLUCOSE BLOOD LEVEL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GASTRIC BANDING; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN SENSITIVITY; LONGITUDINAL STUDY; MALE; METABOLIC REGULATION; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; WEIGHT REDUCTION; GASTROPLASTY; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PHYSIOLOGY; POSTPRANDIAL STATE; PROCEDURES; PROSPECTIVE STUDY;

BLOOD GLUCOSE; FEMALE; GASTRIC BYPASS; GASTROPLASTY; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, MORBID; POSTPRANDIAL PERIOD; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 67650417904     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.79     Document Type: Article

References (43)

1. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002; 288: 1758-1761.
2. Steinbrook R. Surgery for severe obesity. N Engl J Med 2004; 350: 1075-1079.
3. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693.
4. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and metaanalysis. JAMA 2004; 292: 1724-1737.
5. Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004; 89: 2608-2615.
6. Cummings DE, Overduin J, Foster-Schubert KE, Carlson MJ. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis 2007; 3: 109-115.
7. Vincent RP, Ashrafian H, le Roux CW. Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity. Nat Clin Pract 2008; 5: 268-277.
8. Wiedmer P, Nogueiras R, Broglio F, D'Alessio D, Tschöp MH. Ghrelin, obesity and diabetes. Nat Clin Pract Endocrinol Metab2007; 3: 705-712.
9. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-1630.
10. Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ. Exaggerated GLP-1 and blunted GIP secretion are associated with gastric bypass but not gastric banding. Surg Obes Relat Dis 2007; 3: 597-601.
11. Korner J, Inabnet W, Conwell IM, Taveras C, Daud A, Olivero-Rivera L et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity2006; 14: 1553-1561.
12. Vincent RP, le Roux CW. Changes in gut hormones after bariatric surgery. Clin Endocrinol (Oxf) 2008; 69: 173-179.
13. Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005; 90: 359-365.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
15. Chaikomin R, Doran S, Jones KL, Feinle-Bisset C, O'Donovan D, Rayner CK et al. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Am J Physiol Endocrinol Metab 2005; 289: E504-E507.
16. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg 2007; 17: 1193-1198.
17. Buchan AM, Pederson RA, Koop I, Gourlay RH, Cleator IG. Morphological and functional alterations to a sub-group of regulatory peptides in human pancreas and intestine after jejuno-ileal bypass. Int J Obes Relat Metab Disord 1993; 17: 109-113.
18. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJ. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 2006; 93: 210-215.
19. Kellum JM, Kuemmerle JF, O'Dorisio TM, Rayford P, Martin D, Engle K et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg1990; 211: 763-770.
20. Laferrere B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 2479-2485.
21. Muscelli E, Mari A, Casolaro A, Camastra S, Seghieri G, Gastaldelli A et al. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 2008; 57: 1340-1348.
22. Verdich C, Toubro S, Buemann B, Lysgard Madsen J, Juul Holst J, Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satietyFeffect of obesity and weight reduction. Int J Obes Relat Metab Disord 2001; 25: 1206-1214.
23. Morinigo R, Vidal J, Lacy AM, Delgado S, Casamitjana R, Gomis R. Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg 2008; 247: 270-275.
24. le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007; 246: 780-785.
25. Morinigo R, Casamitjana R, Moize VV, Lacy AM, Delgado S, Gomis R et al. Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res 2004; 12: 1108-1116.
26. Jeon TY, Lee S, Kim HH, Kim YJ, Son HC, Kim DH et al. Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab 2004; 89: 5392-5396.
27. Williams DL, Grill HJ, Cummings DE, Kaplan JM. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology 2003; 144: 5184-5187.
28. Lee WJ, Lee YC, Ser KH, Chen JC, Chen SC. Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures. Obes Surg 2008; 18: 1119-1125.
29. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA2008; 299: 316-323.
30. Boey D, Sainsbury A, Herzog H. The role of peptide YY in regulating glucose homeostasis. Peptides 2007; 28: 390-395.
31. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev2007; 87: 1409-1439.
32. Aulinger B, D'Alessio D. Glucagon-like peptide 1: continued advances, new targets and expanding promise as a model therapeutic. Curr Opin Endocrinol Diabetes Obes 2007; 14: 68-73.
33. Kok P, Roelfsema F, Langendonk JG, Frolich M, Burggraaf J, Meinders AE et al. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab 2005; 90: 4659-4663.
34. Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S et al. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 2005; 115: 3579-3586.
35. Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest2003; 111: 1409-1421.
36. Carrasco F, Papapietro K, Csendes A, Salazar G, Echenique C, Lisboa C et al. Changes in resting energy expenditure and body composition after weight loss following Roux-en-Y gastric bypass. Obes Surg 2007; 17: 608-616.
37. Bobbioni-Harsch E, Morel P, Huber O, Assimacopoulos-Jeannet F, Chassot G, Lehmann T et al. Energy economy hampers body weight loss after gastric bypass. J Clin Endocrinol Metab 2000; 85: 4695-4700.
38. Reinehr T, Isa A, de Sousa G, Dieffenbach R, Andler W. Thyroid hormones and their relation to weight status. Horm Res 2008; 70: 51-57.
39. Flier JS, Harris M, Hollenberg AN. Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring. J Clin Invest2000; 105: 859-861.
40. Benoit SC, Clegg DJ, Seeley RJ, Woods SC. Insulin and leptin as adiposity signals. Recent Prog Horm Res 2004; 59: 267-285.
41. Lee M, Wardlaw SL. The central melanocortin system and the regulation of energy balance. Front Biosci 2007; 12: 3994-4010.
42. Korner J, Punyanita M, Taveras C, McMahon DJ, Kim HJ, Inabnet W et al. Sex differences in visceral adipose tissue postbariatric surgery compared to matched non-surgical controls. Int J Body Compos Res 2008; 6: 93-99.
43. Cinti S, de Matteis R, Ceresi E, Pico C, Oliver J, Oliver P et al.Leptin in the human stomach. Gut 2001; 49: 155.